Journal profile · Multiple
JNET
ISSN 1882-4072 · eISSN 2186-2494 · The Japanese Society for Neuroendovascular Therapy · Japan
JNET: CAS Zone 4 · Medicine (2026 Xinrui edition); fully open access; APC charged, amount not published; median 88 days to acceptance (105 articles, last 24 months); 92 articles in 2025; indexed in ESCI.
Scope
Aims, scope and focus
JNET is published by The Japanese Society for Neuroendovascular Therapy and is classed under Medicine in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are Intracranial Aneurysms: Treatment and Complications, Cerebrovascular and Carotid Artery Diseases and Vascular Malformations Diagnosis and Treatment, together about 45.4% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)
JNET Journal of Neuroendovascular Therapy is a peer reviewed, open access journal that publishes significant and novel contributions in neuroendovascular therapy. The journal, which is supported by The Japanese Society for Neuroendovascular Therapy (JSNET), aims to facilitate communication and progress in the field of neurointervention worldwide. Article types include Original Articles, Case Reports, Technical Notes, Anatomical Imaging Articles, Review Articles and Letters to the Editor. The journal publishes articles related to neuroendovascular therapy in the fields of general medicine, social medicine, clinical medicine, and related subjects. Articles can take basic, experimental, applied, or clinical approaches, and the journal welcomes articles that present work at the interface of these areas. The journal provides its authors with rapid but rigorous peer review. Articles are available freely online shortly after acceptance and are freely available to all readers. They are a vital resource for the journal’s broad global audience of researchers and clinicians.
From the journal's Aims & Scope
Research area (LetPub): Multiple
Editor-in-chief Hiro KiyosuePublisher website
Editorial board by country: 2 in mainland China (about 8%); most named Japan 8, Mainland China 2, United States 2, South Korea 2, Germany 2 (26 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Intracranial Aneurysms: Treatment and ComplicationsMedicine20.7%
- Cerebrovascular and Carotid Artery DiseasesMedicine12.9%
- Vascular Malformations Diagnosis and TreatmentMedicine11.9%
- Acute Ischemic Stroke ManagementMedicine9%
- Moyamoya disease diagnosis and treatmentMedicine4.2%
- Legal and Regulatory AnalysisSocial Sciences3.8%
- Linguistic, Cultural, and Literary StudiesSocial Sciences3.8%
- Military Technology and StrategiesEngineering3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
| Minor | Surgery | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 11OpenAlex ·
- i10-index
- 21OpenAlex ·
- 2-year mean citedness
- 0.99OpenAlex ·
- Self-citation rate
- 16.7%LetPub ·
- Share of gold OA articles
- 99.52%LetPub ·
Volume
- Articles per year
- 118LetPub ·
Articles by year OpenAlex count · 1,549 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 86 | 86 | 5 |
| 2025 | 92 | 92 | 93 |
| 2024 | 70 | 70 | 148 |
| 2023 | 44 | 44 | 149 |
| 2022 | 41 | 41 | 79 |
| 2021 | 130 | 130 | 254 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
88 daysMedian, submission to acceptance · P25–P75 65 days – 112 days
- Acceptance to online
- median 32 days (105 articles)
- Submission to online
- median 121 days
- Sample
- 105 articles with submission and acceptance dates (207 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 17 weeksLetPub ·
- Submission to publication (journal-reported)
- about 17 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | JPY 20,000 | Yes | CC BY-NC | |
| OpenAlex | JPY 20,000 | — | — | |
| LetPub | JPY 20,000 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted1
- editorialThe journal uses double-blind peer review. When a manuscript is submitted to the journal, it is assigned to the Editor-in-Chief, who performs initial screening.…Length not stated
Policy excerpts from the journal's websiteLicense & copyright, Peer review
- License & copyright License Notice for JNET Articles
Starting January 1, 2025, JNET has changed its open-access license to CC BY-NC. - Articles that were first published on or after January 1, 2025, are subject to the new CC BY-NC license.- Articles that were published as early access before 2025 remain under the previous CC BY-NC-ND license, even after their transition to final publication, as their original license remains in effect. JNET also tra…
Source ↗Publisher website ·- Peer review Editorial and peer review process
The journal uses double-blind peer review. When a manuscript is submitted to the journal, it is assigned to the Editor-in-Chief, who performs initial screening. Manuscripts that do not fit the journal’s scope or are not deemed suitable for publication are rejected without review. The remaining manuscripts are assigned to an Associate Editor who finds two external reviewers to assess each manuscrip…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- The Japanese Society for Neuroendovascular Therapy
- Country or region
- Japan
- Language
- English
- ISSN
- 1882-4072
- Electronic ISSN
- 2186-2494
- Society / sponsor
- Japanese Society for Neuroendovascular Therapy
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗DOAJ
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about JNET
What CAS zone is JNET in?
In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at JNET?
Based on the dates recorded on 105 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 88 days (interquartile range 65–112 days); authors report an average review time of about 17 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of JNET based?
Of the 26 board members whose country the journal's board page names, 2 (about 8%) are in mainland China; the countries named most often are Japan (8), Mainland China (2) and United States (2). Counted from the institutions listed on the board page; for reference only.
Which databases index JNET?
According to LetPub and DOAJ records, JNET is indexed in ESCI and DOAJ.
Is JNET open access, and what is the APC?
JNET is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .